This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
SIU 2017
SIU 2017 Kidney Cancer
Conferences
AUA 2014
SIU 2017
Prostate Cancer
Kidney Cancer
Bladder Cancer
AUA 2014 - Stones
Viewing 1-20 of 21 articles
#AUA14 - AUA Guideline: Medical management of kidney stones - Slide Presentation
#AUA14 - Renal percutaneous access with the Uro Dyna-CT - Session Highlights
#AUA14 - Direct endoscopic visualization with combined ultrasound guided access during percutaneous nephrolithotomy – a feasibility study and comparison to conventional cohort - Session Highlights
#AUA14 - Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis? - Session Highlights
#AUA14 - A novel genetic model for studying uric acid stone disease - Session Highlights
#AUA14 - Stone prevention with medical management factors affecting compliance and adherence - Session Highlights
#AUA14 - Obese patients taking potassium citrate are less prone to calcium phosphate calculi than non-obese - Session Highlights
#AUA14 - High throughput genetic screening with Drosophila melanogaster identifies novel genes associated with stone formation - Session Highlights
#AUA14 - Do cystine parameters predict clinical stone activity - Session Highlights
#AUA14 - How useful is a negative preoperative urine dipstick analysis in predicting sepsis after percutaneous nephrolithotomy? - Session Highlights
#AUA14 - Pioneering ambulatory PCNL: The Canadian experience - Session Highlights
#AUA14 - Comparative analysis of stone composition and stone culture after percutaneous nephrolithotomy - Session Highlights
#AUA14 - Progress towards a practical protocol to minimize renal injury in extracorporeal shock wave lithotripsy - Session Highlights
#AUA14 - Does combination therapy with tamsulosin and tolterodine improve ureteral stent discomfort compared to monotherapy with tamsulosin? - a randomized controlled trial - Session Highlights
#AUA14 - Correlation between CT density, biochemical structure and microcomposition of urinary stones - Session Highlights
#AUA14 - Quality of life and urolithiasis: The patient-reported outcomes measurement information system (PROMIS) - Session Highlights
#AUA14 - A prospective, multi-institutional study of flexible ureteroscopy for proximal ureteral stones less than 2cm - Session Highlights
#AUA14 - Inappropriate antibiotic utilization for renal colic in the emergency room - Session Highlights
#AUA14 - Novel automated stone detection system to measure renal calculi with ultrasound - Session Highlights
#AUA14 - Safety, minimization and awareness radiation training (SMART) reduces fluoroscopy time during unilateral ureteroscopy - Session Highlights
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free